Literature DB >> 9540876

Endoscopic pancreatic sphincterotomy: indications, outcome, and a safe stentless technique.

E Elton1, D A Howell, W G Parsons, T Qaseem, B L Hanson.   

Abstract

BACKGROUND: Endoscopic pancreatic sphincterotomy is less widely practiced than biliary sphincterotomy, in part because of the lack of firm data regarding its indications and safety. In addition, recent reports of ductal and parenchymal changes occurring after pancreatic stenting raise concerns about the standard practice of stent placement at the time of pancreatic sphincterotomy. We report our experience with pancreatic sphincterotomy and describe the use of a technique involving overnight nasopancreatic drainage rather than stenting.
METHODS: We reviewed the records of the 164 pancreatic sphincterotomies performed on 160 patients at our institution between January 1, 1991, and October 1, 1996, comparing procedures done with overnight nasopancreatic catheter placement with those done with stenting or no drainage. We also examined the long-term clinical outcome of patients after pancreatic sphincterotomy.
RESULTS: Of the 164 sphincterotomies, 98 were done with overnight nasopancreatic drainage, 50 with stent placement, and 16 with no drainage. Complications (all pancreatitis) were significantly more frequent in the group with no drainage (12.5%) as compared with those with drainage (0.7%); p < 0.003. Nasopancreatic drainage was as safe as stent placement, with no complications after 98 procedures. Pancreatic sphincterotomy was effective when used as primary therapy, with 64% of patients so treated experiencing complete and long-lasting resolution of symptoms after the procedure.
CONCLUSIONS: Pancreatic sphincterotomy is safe and effective, although pancreatic drainage is required to reduce the incidence of pancreatitis. Overnight nasopancreatic drainage is the method of choice, as it carries as low a complication rate as stent placement, but without the need for a repeat procedure, and presumably without the risk of ductal and parenchymal damage.

Entities:  

Mesh:

Year:  1998        PMID: 9540876     DOI: 10.1016/s0016-5107(98)70320-7

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


  25 in total

1.  Complications of ERCP.

Authors:  Nalini M Guda; Duvvuru Nageshwar Reddy; Ajay Kumar
Journal:  Indian J Gastroenterol       Date:  2013-09-17

2.  Prophylactic pancreatic stents: does size matter? A comparison of 4-Fr and 5-Fr stents in reference to post-ERCP pancreatitis and migration rate.

Authors:  Albert Pahk; Johanne Rigaux; Vijay Poreddy; Joan Smith; Firas Al-Kawas
Journal:  Dig Dis Sci       Date:  2011-04-13       Impact factor: 3.199

Review 3.  Clinical usefulness and current problems of pancreatic duct stenting for preventing post-ERCP pancreatitis.

Authors:  Yuji Sakai; Toshio Tsuyuguchi; Osamu Yokosuka
Journal:  World J Clin Cases       Date:  2014-09-16       Impact factor: 1.337

4.  SpHincterotomy for Acute Recurrent Pancreatitis Randomized Trial: Rationale, Methodology, and Potential Implications.

Authors:  Gregory A Coté; Valerie L Durkalski-Mauldin; Jose Serrano; Erin Klintworth; April W Williams; Zobeida Cruz-Monserrate; Mustafa Arain; James L Buxbaum; Darwin L Conwell; Evan L Fogel; Martin L Freeman; Timothy B Gardner; Erwin van Geenen; J Royce Groce; Sreenivasa S Jonnalagadda; Rajesh N Keswani; Shyam Menon; Dana C Moffatt; Georgios I Papachristou; Andrew Ross; Paul R Tarnasky; Andrew Y Wang; C Mel Wilcox; Frank Hamilton; Dhiraj Yadav
Journal:  Pancreas       Date:  2019-09       Impact factor: 3.327

5.  A Trial of Rectal Indomethacin to Prevent Post-ERCP Pancreatitis in Patients with Suspected Type 3 Sphincter of Oddi Dysfunction.

Authors:  Ali A Siddiqui; Devi Patel; Jeremy Kaplan; Andrew H Zabolotsky; David Loren; Thomas Kowalski; Saad S Ghumman; Douglas G Adler; Satish Munigal; Umar Hayat; Mohamad A Eloubeidi
Journal:  Dig Dis Sci       Date:  2015-04-14       Impact factor: 3.199

6.  Is there any difference in outcomes between long pigtail and short flanged prophylactic pancreatic duct stents?

Authors:  Shahzad Iqbal; Shashin Shah; Vasudha Dhar; Stavros N Stavropoulos; Peter D Stevens
Journal:  Dig Dis Sci       Date:  2010-05-13       Impact factor: 3.199

Review 7.  Endoscopic treatment of chronic pancreatitis.

Authors:  Laurent Heyries; Jose Sahel
Journal:  World J Gastroenterol       Date:  2007-12-14       Impact factor: 5.742

8.  The sphincter of Oddi and acute pancreatitis--revisited.

Authors:  J Toouli
Journal:  HPB (Oxford)       Date:  2003       Impact factor: 3.647

Review 9.  Pancreatitis after endoscopic retrograde cholangio-pancreatography.

Authors:  Ayman M Abdel Aziz; Glen A Lehman
Journal:  World J Gastroenterol       Date:  2007-05-21       Impact factor: 5.742

Review 10.  Early successes and late failures in the prevention of post endoscopic retrograde cholangiopancreatography.

Authors:  John G Lieb; Peter V Draganov
Journal:  World J Gastroenterol       Date:  2007-07-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.